RPS6KB1 and Other metabolic disease: In turn, the activation of p70S6K by mTORC1 promotes the phosphorylation of IRS1 and reduces its stability, an auto-regulatory pathway or negative feedback loop that has been shown to have profound implications for both metabolic diseases and tumorigenesis [22, 23].